Journal
JOURNAL OF THE ELECTROCHEMICAL SOCIETY
Volume 169, Issue 4, Pages -Publisher
ELECTROCHEMICAL SOC INC
DOI: 10.1149/1945-7111/ac5e42
Keywords
-
Funding
- MIT J-WAFS program
- MIT Research Support Committee
- National Institute of Environmental Health Sciences, National Institutes of Health [P30-ES002109]
- National Institute of Environmental Health Sciences (NIEHS) from the National Institutes of Health (NIH) [T32-ES007020]
Ask authors/readers for more resources
Therapeutic monitoring of neurotransmitters and psychiatric medications is crucial for the diagnosis and treatment of mental illness. However, the in-vivo monitoring of neurotransmitters and continuous physiological monitoring of psychiatrics are yet to be achieved. Electrochemical sensors have been developed for both in-vivo neurotransmitter monitoring and in-vitro detection of psychiatric medications. Further research is needed to achieve concurrent, continuous physiological monitoring of neurotransmitters and psychiatric medications, enabling a closed-loop feedback system for medication administration.
Therapeutic monitoring of neurotransmitters (NTs) and psychiatric medications is essential for the diagnosis and treatment of mental illness. However, in-vivo monitoring of NTs in humans as well as continuous physiological monitoring of psychiatrics have yet to be realized. In pursuit of this goal, there has been a plethora of work to develop electrochemical sensors for both in-vivo NT monitoring as well as in-vitro detection of psychiatric medications. We review these sensors here while discussing next steps needed to achieve concurrent, continuous physiological monitoring of NTs and psychiatric medications as part of a closed-loop feedback system that guides medication administration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available